We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

US FDA Grants Therapy Designation for Roche’s Investigational Medicine ACE910

News   Sep 08, 2015

 
US FDA Grants Therapy Designation for Roche’s Investigational Medicine ACE910
 
 
 

RELATED ARTICLES

Probiotic Gives Long-standing Protection Against Childhood Eczema

News

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

READ MORE

Drug Improves Outcomes & Survival Rates in Patients with Bone Marrow Cancer

News

In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.

READ MORE

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE